HIGHLIGHTS
- who: Publisher`s and colleagues from the , Milan, Italy have published the Article: Cardiac Safety of mRNA-Based Vaccines in Patients with Systemic and Lupus-like Disorders with History of Myocarditis Unit of Immunology Rheumatology Allergy and Rare Diseases IRCCS Ospedale San Raffaele, in the Journal: Pathogens 2022, 11, 1001. of /2022/
- what: We have shown that mRNA-based anti-SARS-CoV-2 vaccines can apparently be safely administered to patients with SLE and lupus-like disorders with previous myocarditis, despite potential subclinical and transient rises in cardiac damage markers.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.